CN Stock MarketDetailed Quotes

Landfar Bio-medicine (000504)

Watchlist
  • 9.80
  • -0.08-0.81%
Market Closed Apr 17 15:00 CST
3.23BMarket Cap-515.79P/E (TTM)

Landfar Bio-medicine (000504) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
-9.72%83.44M
-8.40%51.59M
-13.55%22.45M
-1.71%134.45M
-11.78%92.42M
-20.03%56.32M
-25.23%25.97M
-31.72%136.79M
-33.02%104.76M
-35.84%70.43M
Operating revenue
-9.72%83.44M
-8.40%51.59M
-13.55%22.45M
-1.71%134.45M
-11.78%92.42M
-20.03%56.32M
-25.23%25.97M
-31.72%136.79M
-33.02%104.76M
-35.84%70.43M
Other operating revenue
----
-34.86%128.11K
----
-45.27%190.9K
----
-18.35%196.66K
----
-94.05%348.83K
----
-95.75%240.86K
Total operating cost
-8.13%87.43M
5.03%65.25M
0.25%30.06M
-12.43%137.82M
-15.92%95.17M
-18.01%62.13M
-16.29%29.98M
-24.07%157.38M
-25.74%113.19M
-31.32%75.77M
Operating cost
3.30%30.52M
-5.21%18.6M
-14.57%7.87M
0.28%43.81M
-14.04%29.54M
-17.25%19.62M
-15.29%9.21M
-38.07%43.69M
-43.43%34.37M
-52.26%23.71M
Operating tax surcharges
-7.20%592.18K
-20.89%346.86K
-20.11%173.8K
0.80%1.23M
-18.27%638.14K
-11.51%438.46K
1.83%217.54K
8.77%1.22M
0.43%780.81K
8.94%495.48K
Operating expense
-24.35%17.25M
-13.61%12.97M
-7.72%6.84M
-19.76%30.82M
-17.66%22.81M
-18.54%15.01M
-15.21%7.41M
-36.45%38.4M
-24.63%27.7M
-25.46%18.42M
Administration expense
-6.66%33.03M
22.99%28.38M
16.68%12.35M
0.23%52.52M
-3.27%35.38M
-5.09%23.08M
-10.47%10.59M
-2.26%52.39M
-4.24%36.58M
-0.70%24.31M
Financial expense
16.55%-195.7K
-154.70%-217.58K
-98.05%7.23K
-102.62%-238.52K
-103.43%-234.5K
-101.91%-85.42K
-81.12%370.99K
-21.37%9.11M
-24.55%6.83M
-32.95%4.46M
-Interest expense (Financial expense)
-47.69%650.21K
-39.10%497.69K
-67.02%233.96K
-86.79%1.46M
-83.75%1.24M
-84.30%817.17K
-74.11%709.47K
-14.20%11.07M
-23.23%7.65M
-22.62%5.21M
-Interest Income (Financial expense)
36.56%-1.07M
21.22%-840.89K
29.67%-294.44K
13.62%-2.03M
0.29%-1.69M
23.31%-1.07M
52.13%-418.68K
-32.06%-2.35M
-29.58%-1.7M
-58.01%-1.39M
Research and development
-11.34%6.24M
27.30%5.18M
28.93%2.82M
-22.87%9.69M
1.37%7.03M
-6.75%4.07M
-0.60%2.18M
25.86%12.57M
0.63%6.94M
0.47%4.36M
Credit Impairment Loss
26.02%-4.17M
29.56%-4.17M
--545.55K
33.12%-22.39M
-131.28%-5.63M
-142.89%-5.92M
----
-35.67%-33.47M
-560.59%-2.44M
-571.02%-2.44M
Asset Impairment Loss
----
----
----
93.21%-471.2K
-83,035.38%-1.96M
----
----
-227.38%-6.94M
-100.90%-2.36K
-727.78%-2.36K
Other net revenue
132.04%1.51M
89.28%-563.51K
33.76%2.05M
30.60%-17.44M
-135.39%-4.71M
-390.84%-5.26M
68.62%1.53M
-30.66%-25.12M
201.82%13.3M
-146.47%-1.07M
Fair value change income
-84.60%-151.26K
13.37%-145.9K
-81.45%-160.98K
-119.98%-6.63K
61.68%-81.94K
-104.65%-168.42K
-468.36%-88.72K
156.35%33.18K
46.80%-213.83K
71.65%-82.3K
Invest income
154.14%5.31M
669.52%3.42M
16.34%1.58M
300.79%3.69M
165.42%2.09M
-22.98%444.04K
531.74%1.36M
23,776.68%920.55K
656.15%787.24K
311.57%576.55K
-Including: Investment income associates
----
----
----
-3,887.03%-2.73M
-1,273.19%-60.72K
-61,493.63%-2.72M
----
86.04%-68.51K
95.37%-4.42K
95.37%-4.42K
Asset deal income
108.86%32.48K
--32.48K
---206.43
-98.69%155.7K
-102.66%-366.44K
----
----
13,973.43%11.9M
18,436.73%13.77M
-173.03%-54.25K
Other revenue
-61.19%484.14K
-21.35%300.65K
-67.23%86.54K
-34.81%1.58M
-10.68%1.25M
-58.76%382.27K
-62.77%264.12K
-67.78%2.43M
-65.80%1.4M
-59.30%926.83K
Operating profit
66.73%-2.48M
-28.60%-14.22M
-124.34%-5.55M
54.47%-20.81M
-253.25%-7.46M
-72.66%-11.06M
-1,389.25%-2.48M
-74.82%-45.71M
-42.00%4.87M
-463.60%-6.41M
Add:Non operating Income
649.45%1.59K
649.14%1.59K
--1.59K
-99.98%212.71
-99.98%212.69
-99.98%212.69
----
-78.28%1.01M
-78.37%1.01M
-78.43%1M
Less:Non operating expense
3,250.65%631.45K
5,487.52%380.31K
20,798.88%380.31K
1,862.64%37.82K
897.90%18.85K
467.67%6.81K
51.77%1.82K
-95.45%1.93K
-94.58%1.89K
-92.60%1.2K
Total profit
58.38%-3.11M
-31.94%-14.6M
-139.46%-5.93M
53.36%-20.85M
-227.34%-7.48M
-104.71%-11.07M
-397.58%-2.48M
-107.38%-44.71M
-54.87%5.87M
-184.66%-5.41M
Less:Income tax cost
-97.27%38.55K
-195.44%-537.64K
59.74%589.38K
48.48%3.07M
21.51%1.41M
35.45%563.35K
-6.52%368.97K
-73.80%2.07M
-76.05%1.16M
-83.42%415.92K
Net profit
64.55%-3.15M
-20.93%-14.06M
-129.12%-6.52M
48.86%-23.93M
-288.69%-8.89M
-99.77%-11.63M
-750.09%-2.85M
-58.79%-46.78M
-42.29%4.71M
-250.16%-5.82M
Net profit from continuing operation
64.55%-3.15M
-20.93%-14.06M
-129.12%-6.52M
48.86%-23.93M
-288.69%-8.89M
-99.77%-11.63M
-750.09%-2.85M
-58.79%-46.78M
-42.29%4.71M
-250.16%-5.82M
Less:Minority Profit
-1,664.40%-8.38M
-226.86%-10.58M
-5,571.48%-4.3M
78.08%-4.08M
-111.25%-475.06K
-202.68%-3.24M
-103.14%-75.88K
-9.44%-18.61M
-44.58%4.22M
84.34%3.15M
Net profit of parent company owners
162.21%5.23M
58.48%-3.48M
19.92%-2.22M
29.56%-19.85M
-1,828.05%-8.41M
6.47%-8.39M
-40.21%-2.77M
-126.15%-28.17M
-9.99%486.72K
-514.10%-8.97M
Earning per share
Basic earning per share
162.35%0.0159
58.27%-0.0106
20.24%-0.0067
33.33%-0.06
-1,693.75%-0.0255
11.81%-0.0254
-33.33%-0.0084
-125.00%-0.09
-5.88%0.0016
-511.43%-0.0288
Diluted earning per share
162.35%0.0159
58.27%-0.0106
20.24%-0.0067
33.33%-0.06
-1,693.75%-0.0255
11.81%-0.0254
-33.33%-0.0084
-125.00%-0.09
-5.88%0.0016
-511.43%-0.0288
Other composite income
Total composite income
64.55%-3.15M
-20.93%-14.06M
-129.12%-6.52M
48.86%-23.93M
-288.69%-8.89M
-99.77%-11.63M
-750.09%-2.85M
-58.79%-46.78M
-42.29%4.71M
-250.16%-5.82M
Total composite income of parent company owners
162.21%5.23M
58.48%-3.48M
19.92%-2.22M
29.56%-19.85M
-1,828.05%-8.41M
6.47%-8.39M
-40.21%-2.77M
-126.15%-28.17M
-9.99%486.72K
-514.10%-8.97M
Total composite income of minority owners
-1,664.40%-8.38M
-226.86%-10.58M
-5,571.48%-4.3M
78.08%-4.08M
-111.25%-475.06K
-202.68%-3.24M
-103.14%-75.88K
-9.44%-18.61M
-44.58%4.22M
84.34%3.15M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue -9.72%83.44M-8.40%51.59M-13.55%22.45M-1.71%134.45M-11.78%92.42M-20.03%56.32M-25.23%25.97M-31.72%136.79M-33.02%104.76M-35.84%70.43M
Operating revenue -9.72%83.44M-8.40%51.59M-13.55%22.45M-1.71%134.45M-11.78%92.42M-20.03%56.32M-25.23%25.97M-31.72%136.79M-33.02%104.76M-35.84%70.43M
Other operating revenue -----34.86%128.11K-----45.27%190.9K-----18.35%196.66K-----94.05%348.83K-----95.75%240.86K
Total operating cost -8.13%87.43M5.03%65.25M0.25%30.06M-12.43%137.82M-15.92%95.17M-18.01%62.13M-16.29%29.98M-24.07%157.38M-25.74%113.19M-31.32%75.77M
Operating cost 3.30%30.52M-5.21%18.6M-14.57%7.87M0.28%43.81M-14.04%29.54M-17.25%19.62M-15.29%9.21M-38.07%43.69M-43.43%34.37M-52.26%23.71M
Operating tax surcharges -7.20%592.18K-20.89%346.86K-20.11%173.8K0.80%1.23M-18.27%638.14K-11.51%438.46K1.83%217.54K8.77%1.22M0.43%780.81K8.94%495.48K
Operating expense -24.35%17.25M-13.61%12.97M-7.72%6.84M-19.76%30.82M-17.66%22.81M-18.54%15.01M-15.21%7.41M-36.45%38.4M-24.63%27.7M-25.46%18.42M
Administration expense -6.66%33.03M22.99%28.38M16.68%12.35M0.23%52.52M-3.27%35.38M-5.09%23.08M-10.47%10.59M-2.26%52.39M-4.24%36.58M-0.70%24.31M
Financial expense 16.55%-195.7K-154.70%-217.58K-98.05%7.23K-102.62%-238.52K-103.43%-234.5K-101.91%-85.42K-81.12%370.99K-21.37%9.11M-24.55%6.83M-32.95%4.46M
-Interest expense (Financial expense) -47.69%650.21K-39.10%497.69K-67.02%233.96K-86.79%1.46M-83.75%1.24M-84.30%817.17K-74.11%709.47K-14.20%11.07M-23.23%7.65M-22.62%5.21M
-Interest Income (Financial expense) 36.56%-1.07M21.22%-840.89K29.67%-294.44K13.62%-2.03M0.29%-1.69M23.31%-1.07M52.13%-418.68K-32.06%-2.35M-29.58%-1.7M-58.01%-1.39M
Research and development -11.34%6.24M27.30%5.18M28.93%2.82M-22.87%9.69M1.37%7.03M-6.75%4.07M-0.60%2.18M25.86%12.57M0.63%6.94M0.47%4.36M
Credit Impairment Loss 26.02%-4.17M29.56%-4.17M--545.55K33.12%-22.39M-131.28%-5.63M-142.89%-5.92M-----35.67%-33.47M-560.59%-2.44M-571.02%-2.44M
Asset Impairment Loss ------------93.21%-471.2K-83,035.38%-1.96M---------227.38%-6.94M-100.90%-2.36K-727.78%-2.36K
Other net revenue 132.04%1.51M89.28%-563.51K33.76%2.05M30.60%-17.44M-135.39%-4.71M-390.84%-5.26M68.62%1.53M-30.66%-25.12M201.82%13.3M-146.47%-1.07M
Fair value change income -84.60%-151.26K13.37%-145.9K-81.45%-160.98K-119.98%-6.63K61.68%-81.94K-104.65%-168.42K-468.36%-88.72K156.35%33.18K46.80%-213.83K71.65%-82.3K
Invest income 154.14%5.31M669.52%3.42M16.34%1.58M300.79%3.69M165.42%2.09M-22.98%444.04K531.74%1.36M23,776.68%920.55K656.15%787.24K311.57%576.55K
-Including: Investment income associates -------------3,887.03%-2.73M-1,273.19%-60.72K-61,493.63%-2.72M----86.04%-68.51K95.37%-4.42K95.37%-4.42K
Asset deal income 108.86%32.48K--32.48K---206.43-98.69%155.7K-102.66%-366.44K--------13,973.43%11.9M18,436.73%13.77M-173.03%-54.25K
Other revenue -61.19%484.14K-21.35%300.65K-67.23%86.54K-34.81%1.58M-10.68%1.25M-58.76%382.27K-62.77%264.12K-67.78%2.43M-65.80%1.4M-59.30%926.83K
Operating profit 66.73%-2.48M-28.60%-14.22M-124.34%-5.55M54.47%-20.81M-253.25%-7.46M-72.66%-11.06M-1,389.25%-2.48M-74.82%-45.71M-42.00%4.87M-463.60%-6.41M
Add:Non operating Income 649.45%1.59K649.14%1.59K--1.59K-99.98%212.71-99.98%212.69-99.98%212.69-----78.28%1.01M-78.37%1.01M-78.43%1M
Less:Non operating expense 3,250.65%631.45K5,487.52%380.31K20,798.88%380.31K1,862.64%37.82K897.90%18.85K467.67%6.81K51.77%1.82K-95.45%1.93K-94.58%1.89K-92.60%1.2K
Total profit 58.38%-3.11M-31.94%-14.6M-139.46%-5.93M53.36%-20.85M-227.34%-7.48M-104.71%-11.07M-397.58%-2.48M-107.38%-44.71M-54.87%5.87M-184.66%-5.41M
Less:Income tax cost -97.27%38.55K-195.44%-537.64K59.74%589.38K48.48%3.07M21.51%1.41M35.45%563.35K-6.52%368.97K-73.80%2.07M-76.05%1.16M-83.42%415.92K
Net profit 64.55%-3.15M-20.93%-14.06M-129.12%-6.52M48.86%-23.93M-288.69%-8.89M-99.77%-11.63M-750.09%-2.85M-58.79%-46.78M-42.29%4.71M-250.16%-5.82M
Net profit from continuing operation 64.55%-3.15M-20.93%-14.06M-129.12%-6.52M48.86%-23.93M-288.69%-8.89M-99.77%-11.63M-750.09%-2.85M-58.79%-46.78M-42.29%4.71M-250.16%-5.82M
Less:Minority Profit -1,664.40%-8.38M-226.86%-10.58M-5,571.48%-4.3M78.08%-4.08M-111.25%-475.06K-202.68%-3.24M-103.14%-75.88K-9.44%-18.61M-44.58%4.22M84.34%3.15M
Net profit of parent company owners 162.21%5.23M58.48%-3.48M19.92%-2.22M29.56%-19.85M-1,828.05%-8.41M6.47%-8.39M-40.21%-2.77M-126.15%-28.17M-9.99%486.72K-514.10%-8.97M
Earning per share
Basic earning per share 162.35%0.015958.27%-0.010620.24%-0.006733.33%-0.06-1,693.75%-0.025511.81%-0.0254-33.33%-0.0084-125.00%-0.09-5.88%0.0016-511.43%-0.0288
Diluted earning per share 162.35%0.015958.27%-0.010620.24%-0.006733.33%-0.06-1,693.75%-0.025511.81%-0.0254-33.33%-0.0084-125.00%-0.09-5.88%0.0016-511.43%-0.0288
Other composite income
Total composite income 64.55%-3.15M-20.93%-14.06M-129.12%-6.52M48.86%-23.93M-288.69%-8.89M-99.77%-11.63M-750.09%-2.85M-58.79%-46.78M-42.29%4.71M-250.16%-5.82M
Total composite income of parent company owners 162.21%5.23M58.48%-3.48M19.92%-2.22M29.56%-19.85M-1,828.05%-8.41M6.47%-8.39M-40.21%-2.77M-126.15%-28.17M-9.99%486.72K-514.10%-8.97M
Total composite income of minority owners -1,664.40%-8.38M-226.86%-10.58M-5,571.48%-4.3M78.08%-4.08M-111.25%-475.06K-202.68%-3.24M-103.14%-75.88K-9.44%-18.61M-44.58%4.22M84.34%3.15M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More